These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2285291)
21. Differentiation of multiresistant Klebsiella pneumoniae isolates by a double-disc diffusion test for detecting extended-spectrum beta-lactamases. Blahová J; Kraliková K; Krcméry V; Torsová V J Antimicrob Chemother; 1997 Aug; 40(2):306-7. PubMed ID: 9302004 [No Abstract] [Full Text] [Related]
22. Cefepime and the inoculum effect in tests with Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase. Kang CI; Pai H; Kim SH; Kim HB; Kim EC; Oh MD; Choe KW J Antimicrob Chemother; 2004 Dec; 54(6):1130-3. PubMed ID: 15486080 [TBL] [Abstract][Full Text] [Related]
23. Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. Siu LK; Lu PL; Hsueh PR; Lin FM; Chang SC; Luh KT; Ho M; Lee CY J Clin Microbiol; 1999 Dec; 37(12):4020-7. PubMed ID: 10565924 [TBL] [Abstract][Full Text] [Related]
24. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases. Conejo MC; Hernández JR; Pascual A Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of resistance and antibacterial susceptibility in extended-spectrum β-lactamase phenotype Klebsiella pneumoniae and Klebsiella oxytoca isolated between 2000 and 2010 in Japan. Sato T; Hara T; Horiyama T; Kanazawa S; Yamaguchi T; Maki H J Med Microbiol; 2015 May; 64(Pt 5):538-543. PubMed ID: 25813819 [TBL] [Abstract][Full Text] [Related]
31. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae. Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600 [TBL] [Abstract][Full Text] [Related]
32. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations. de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935 [No Abstract] [Full Text] [Related]
33. A preliminary survey of extended-spectrum beta-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. Yagi T; Kurokawa H; Shibata N; Shibayama K; Arakawa Y FEMS Microbiol Lett; 2000 Mar; 184(1):53-6. PubMed ID: 10689165 [TBL] [Abstract][Full Text] [Related]
34. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae. Burgess DS; Hall RG Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499 [TBL] [Abstract][Full Text] [Related]
35. SHV Hyperproduction as a Mechanism for Piperacillin-Tazobactam Resistance in Extended-Spectrum Cephalosporin-Susceptible Han MS; Park KS; Jeon JH; Lee JK; Lee JH; Choi EH; Lee SH Microb Drug Resist; 2020 Apr; 26(4):334-340. PubMed ID: 31651221 [TBL] [Abstract][Full Text] [Related]
36. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases. Bedenic B; Vranes J; Suto S; Zagar Z Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465 [TBL] [Abstract][Full Text] [Related]
37. Phenotypic and molecular characterization of extended-spectrum β-lactamases and AmpC β-lactamases in Klebsiella pneumoniae. Al-Agamy MH Pak J Pharm Sci; 2013 Mar; 26(2):291-8. PubMed ID: 23455199 [TBL] [Abstract][Full Text] [Related]
38. Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC beta-lactamases. Essack SY; Hall LM; Livermore DM Int J Antimicrob Agents; 2004 Apr; 23(4):398-400. PubMed ID: 15081091 [TBL] [Abstract][Full Text] [Related]
39. Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands. Mazzariol A; Roelofsen E; Koncan R; Voss A; Cornaglia G Antimicrob Agents Chemother; 2007 Mar; 51(3):1082-4. PubMed ID: 17178800 [TBL] [Abstract][Full Text] [Related]
40. Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea. Kim J; Kwon Y; Pai H; Kim JW; Cho DT J Clin Microbiol; 1998 May; 36(5):1446-9. PubMed ID: 9574728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]